Wordt geladen...
Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors
The receptor-activator of nuclear kappaB ligand (RANKL) signaling pathway plays an important role in the regulation of bone growth and mediates the formation and activation of osteoclasts. Osteoclasts are involved in significant bone resorption and destruction. Denosumab is a fully human monoclonal...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862691/ https://ncbi.nlm.nih.gov/pubmed/27163152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0154680 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|